Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis

Ikuo Tsunoda1, Jane E Libbey, Li-Qing Kuang

  • 1Department of Neurology, University of Utah School of Medicine, Salt Lake City, 84132-2305, USA.

Insights

Lymphoid apoptosis contributes to progressive multiple sclerosis by altering immune responses and increasing myelin oligodendrocyte glycoprotein antibody production, leading to demyelination. This finding helps understand different multiple sclerosis forms.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • The mechanisms differentiating multiple sclerosis (MS) forms, such as primary progressive (PPMS), secondary progressive (SPMS), and relapsing-remitting (RRMS), remain unclear.
  • Animal models are crucial for studying MS pathogenesis and potential therapeutic targets.

Purpose of the Study:

  • To investigate the role of lymphoid apoptosis in the progression of experimental allergic encephalomyelitis (EAE), an animal model for MS.
  • To elucidate the mechanisms underlying the distinct EAE forms (PP/SP-EAE vs. RR-EAE) using myelin oligodendrocyte glycoprotein (MOG)(92-106) as a target.

Main Methods:

  • Established distinct EAE models in A.SW (PP/SP-EAE) and SJL/J (RR-EAE) mice using MOG(92-106).
  • Analyzed lymphoid organ pathology (thymus, spleen, lymph nodes) and cellular apoptosis in A.SW mice with progressive EAE.
  • Induced SP-EAE in SJL/J mice by injecting apoptotic thymocytes and assessed disease severity, demyelination, MOG antibody titers, and immune cell function.

Main Results:

  • A.SW mice with progressive EAE exhibited lymphoid atrophy, T and B cell depletion, and massive apoptosis.
  • SJL/J mice injected with apoptotic thymocytes developed SP-EAE, characterized by significant demyelination, high MOG antibody titers, and lymphoid atrophy.
  • Spleen cells from progressive EAE mice produced less interferon-gamma upon stimulation compared to those from RR-EAE mice.

Conclusions:

  • Induction of lymphoid apoptosis may drive MS disease progression by shifting the Th1/Th2 immune balance and elevating MOG antibody production.
  • This mechanism contributes to increased demyelination and exacerbation of MS symptoms, potentially explaining differences between MS forms.